Literature DB >> 15632144

Phosphoinositide binding by the disabled-1 PTB domain is necessary for membrane localization and Reelin signal transduction.

Peggy C Stolt1, Ying Chen, Pingsheng Liu, Hans H Bock, Stephen C Blacklow, Joachim Herz.   

Abstract

Disabled-1 (Dab1) is an essential adaptor protein that functions in the Reelin signaling pathway and is required for the regulation of neuronal migration during embryonic development. Dab1 interacts with NPXY motifs in the cytoplasmic tails of the lipoprotein receptors ApoER2 and very low density lipoprotein receptor through an amino-terminal phosphotyrosine binding (PTB) domain. Binding of Reelin to these receptors leads to tyrosine phosphorylation of Dab1 and the initiation of a signaling cascade that results in remodeling of the cytoskeleton. Structural and biochemical studies of the Dab1 PTB domain have demonstrated that this domain binds to both the NPXY peptide motif in the lipoprotein receptor tails as well as to the head group of phosphoinositide 4,5-P2 through energetically independent mechanisms. Here we have investigated how phosphoinositide binding by the Dab1 PTB domain influences Reelin signal transduction. Our findings in cultured primary neurons that have been transduced with lentiviral constructs expressing mutant Dab1 forms reveal that phosphoinositide binding by the Dab1 PTB domain is necessary for proper membrane localization of Dab1 and for effective transduction of a Reelin signal.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632144     DOI: 10.1074/jbc.M413356200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family.

Authors:  Marco Dieckmann; Martin Frederik Dietrich; Joachim Herz
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

2.  Reconstitution of the Reelin signaling pathway in fibroblasts demonstrates that Dab1 phosphorylation is independent of receptor localization in lipid rafts.

Authors:  Harald Mayer; Sarah Duit; Christoph Hauser; Wolfgang J Schneider; Johannes Nimpf
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

3.  Both the phosphoinositide and receptor binding activities of Dab1 are required for Reelin-stimulated Dab1 tyrosine phosphorylation.

Authors:  Mei Xu; Lionel Arnaud; Jonathan A Cooper
Journal:  Brain Res Mol Brain Res       Date:  2005-10-03

4.  A genetic interaction between the APP and Dab1 genes influences brain development.

Authors:  Albéna Pramatarova; Kelian Chen; Brian W Howell
Journal:  Mol Cell Neurosci       Date:  2007-09-26       Impact factor: 4.314

5.  The AP-2 adaptor beta2 appendage scaffolds alternate cargo endocytosis.

Authors:  Peter A Keyel; James R Thieman; Robyn Roth; Elif Erkan; Eric T Everett; Simon C Watkins; John E Heuser; Linton M Traub
Journal:  Mol Biol Cell       Date:  2008-10-08       Impact factor: 4.138

Review 6.  Reelin and apolipoprotein E receptor 2 in the embryonic and mature brain: effects of an evolutionary change in the apoER2 gene.

Authors:  Nicolas B Myant
Journal:  Proc Biol Sci       Date:  2009-10-21       Impact factor: 5.349

Review 7.  Polyphosphoinositide-Binding Domains: Insights from Peripheral Membrane and Lipid-Transfer Proteins.

Authors:  Joshua G Pemberton; Tamas Balla
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 8.  Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.

Authors:  David M Holtzman; Joachim Herz; Guojun Bu
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

9.  NOS1AP Functionally Associates with YAP To Regulate Hippo Signaling.

Authors:  Leanne Clattenburg; Michael Wigerius; Jiansong Qi; Jan K Rainey; Jillian L Rourke; Shanmugam Muruganandan; Christopher J Sinal; James P Fawcett
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

10.  Sulfatides partition disabled-2 in response to platelet activation.

Authors:  Karen E Drahos; John D Welsh; Carla V Finkielstein; Daniel G S Capelluto
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.